Core Insights - Haleon is intensifying its expansion in China, focusing on second- and third-tier cities and customizing its gum-health products to local preferences, aiming to succeed where many Western brands have struggled [1] Company Strategy - Haleon is investing £65 million ($87 million) in a new oral-health factory in Shanghai to support its growth strategy in China [1] - The company aims to expand its Parodontax brand into over 30 cities by the end of 2027, addressing a significant consumer need as over 70% of Chinese consumers suffer from gum health issues [1][1] Market Context - China represents about 10% of Haleon's £11 billion business and nearly 13% of the $59 billion global oral-health market, which is projected to reach approximately $80 billion by 2031 [1] - Haleon's Sensodyne toothpaste is experiencing mid-teens growth, with around 11% of Chinese households using the brand, compared to local leader Yunnan Baiyao at 29.8% [1] Product Adaptation - The Parodontax brand was relaunched in China with modifications to suit local tastes, including a sweeter flavor, foamier texture, and glossier packaging, now available in 10,000 outlets across 19 cities [1][1] Competitive Landscape - Many Western companies, such as Starbucks and Nike, are scaling back their operations in China due to weak sales, while Haleon has taken a different approach by buying out the Chinese government from its local joint venture for approximately £700 million [1]

Core Insights - Haleon has appointed Kedar Lele as the new President for the India Subcontinent, effective this month, succeeding Navneet Saluja who retired in October 2025 [1][3] - Lele brings over 25 years of experience in various sectors, including FMCG, and will be part of Haleon's Executive Team, focusing on the company's strategy to reach 1 billion more consumers by 2030 [3][4] Company Overview - Haleon is a consumer healthcare company based in England, offering over-the-counter products for everyday health needs, with a focus on oral care, digestive health, pain management, respiratory health, and vitamin and mineral supplements [6] - The company markets well-known brands such as Eno, Sensodyne, Iodex, Crocin, Otrivin, Centrum, Ostocalcium, Parodontax, and Polident in India [6] Leadership Background - Kedar Lele previously served as Managing Director at Castrol India Ltd and has nearly two decades of experience at Hindustan Unilever Ltd, where he held senior roles including Executive Director for Sales and Customer Development in South Asia [2][4] - Lele holds an MBA in Strategic Marketing and Operations from the Indian School of Business and has served on the board of TVS Automobile Solutions [5]